Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib, Compared to DTPa-HBV-IPV and Hib Administered Separately

NCT01457508 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

440

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B
Diphtheria
Haemophilus Influenzae Type b (Hib)
Poliomyelitis
Pertussis
Tetanus

Interventions

BIOLOGICAL: DTPa-HBV-IPV/Hib (Infanrix hexa™)
BIOLOGICAL: DTPa-HBV-IPV (Infanrix penta™)
BIOLOGICAL: Hib (Hiberix™)

Sponsor

GlaxoSmithKline